Trade Cogent Biosciences, Inc. - COGT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.16
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021596 %(-$4.32)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02160%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000626 %(-$0.13)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021596 %
  (-$4.32)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000626 %
  (-$0.13)

Key Stats

• Prev. Close: 37.78
• Open: 37.63
• 1-Year Change: 217.28%
• Day's Range: 37.01 - 37.88

Trade Cogent Biosciences, Inc. - COGT

What is Cogent Biosciences, Inc. (COGT)?

Cogent Biosciences, Inc. is a biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company specializes in targeting molecular pathways that contribute to tumor growth and resistance, aiming to address unmet medical needs in oncology. Its research and development efforts include small molecule inhibitors designed to modulate specific biological targets implicated in various malignancies. Cogent Biosciences operates within the broader biotechnology industry, collaborating with academic institutions and leveraging scientific advancements to advance its pipeline. The company’s approach integrates medicinal chemistry, biology, and translational research to develop potential therapeutic candidates. It is involved in preclinical and clinical stages of drug development, with a focus on safety and efficacy profiles. Cogent Biosciences contributes to the evolving landscape of cancer treatment by exploring innovative mechanisms of action and personalized medicine strategies. The company’s activities encompass discovery, development, and potential commercialization of cancer therapies aimed at improving patient outcomes.

Cogent Biosciences, Inc. Stock Price Today: Live Overview

The price today is shaped by live market flows, with Cogent Biosciences, Inc. trading at $37.51. Price action fluctuated between $36.96 and $38.04 during the day, showing a daily change of -1.5559%.

FAQ: Cogent Biosciences, Inc. (COGT)

What is the current price of COGT stock?

The current price is $37.51.

Does COGT pay dividends?

Cogent Biosciences, Inc. does not pay dividends.

Does COGT have a formal corporate presence or regional headquarters in the UAE?

Cogent Biosciences, Inc. has no official office or subsidiary in the UAE and operates via partners or distributors.

What is COGT best known for?

Cogent Biosciences, Inc. is most famous for its development of targeted cancer therapies.

What assets are typically shown together with COGT?

Commonly shown alongside COGT: MicroSectors FANG+ Index -3X Inverse Leveraged ETN, Wizz Air, BlackRock Multi-Sector Income T